Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,…
2024-07-05 21:32:00
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,…
[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become…
[ad_1] The logo of Danish pharmaceutical company is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February…
[ad_1] Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data,…
[ad_1] Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or…
[ad_1] Arc of Triomphe Paris, Champs-Elysees France at night vichie81 / iStock / Getty Images Plus LONDON — Around a…
[ad_1] Here are the most important news items that investors need to start their trading day: 1. Downtick Stock futures…
[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and…
[ad_1] The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024. …
[ad_1] Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12,…